↓ Skip to main content

Gene replacement therapy for retinal CNG channelopathies

Overview of attention for article published in Molecular Genetics and Genomics, July 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
53 Mendeley
citeulike
1 CiteULike
Title
Gene replacement therapy for retinal CNG channelopathies
Published in
Molecular Genetics and Genomics, July 2013
DOI 10.1007/s00438-013-0766-4
Pubmed ID
Authors

Christian Schön, Martin Biel, Stylianos Michalakis

Abstract

Visual phototransduction relies on the function of cyclic nucleotide-gated channels in the rod and cone photoreceptor outer segment plasma membranes. The role of these ion channels is to translate light-triggered changes in the second messenger cyclic guanosine 3'-5'-monophosphate levels into an electrical signal that is further processed within the retinal network and then sent to higher visual centers. Rod and cone photoreceptors express distinct CNG channels. The rod photoreceptor CNG channel is composed of one CNGB1 and three CNGA1 subunits, whereas the cone channel is formed by one CNGB3 and three CNGA3 subunits. Mutations in any of these channel subunits result in severe and currently untreatable retinal degenerative diseases like retinitis pigmentosa or achromatopsia. In this review, we provide an overview of the human diseases and relevant animal models of CNG channelopathies. Furthermore, we summarize recent results from preclinical gene therapy studies using adeno-associated viral vectors and discuss the efficacy and translational potential of these gene therapeutic approaches.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Unknown 52 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 28%
Student > Ph. D. Student 6 11%
Student > Master 6 11%
Professor > Associate Professor 4 8%
Student > Doctoral Student 3 6%
Other 13 25%
Unknown 6 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 11 21%
Medicine and Dentistry 10 19%
Biochemistry, Genetics and Molecular Biology 8 15%
Neuroscience 8 15%
Psychology 4 8%
Other 4 8%
Unknown 8 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2013.
All research outputs
#20,656,820
of 25,374,647 outputs
Outputs from Molecular Genetics and Genomics
#2,974
of 3,318 outputs
Outputs of similar age
#145,942
of 191,893 outputs
Outputs of similar age from Molecular Genetics and Genomics
#3
of 3 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,318 research outputs from this source. They receive a mean Attention Score of 4.0. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,893 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.